🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

"Direct oral anticoagulants after bariatric surgery-What is the evidence?" Read the summarize of evidence in this analysis supporting the use of #DOACs after #bariatric surgery - Siraj Mithoowani buff.ly/3A989Jw #Research #Thrombosis #Evidence

Need I say more

.McMaster University researcher and educator Teresa Chan | 陳敏怡 is receiving the 2022 Universitas 21 Health Sciences Group (HSG) Teaching Excellence Award. Congratulations Dr. Chan! ow.ly/ybcM50LaM49

Step into the Quantum Realm. Marvel Studios’ Ant-Man and The Wasp: Quantumania in theatres tomorrow.

A welcome note to the 9th COMy Congress by Dr. Hira Mian Hira Mian Be sure to register TODAY and enjoy discounted fees👉bit.ly/3ZSb31v Paris 🇫🇷 or Online🌐 May 11-14 2023 View the full CME accredited program👉bit.ly/3kuzGkq Mohamad Mohty Arnon Nagler

Bravo to our CAME-ACEM 2023 Certificate of Merit Award winners! Today we’re celebrating Dr. Rahim Kachra, MD'10, PGME'15. He is a driving force in medical education at #UCalgaryMed as a leader and role model. Read more: came-acem.ca/awards/came-ce… Department of Medicine O'Brien Institute for Public Health Undergraduate Medical Education

Thank you ⁦CCTG⁩ ⁦@AncaPrica⁩ ⁦Annette Hay⁩ ⁦Joe pater⁩ for the mentorship! ⁦@ECRI_RESEARCH⁩ ⁦Hamilton Health Sciences⁩ link.springer.com/article/10.100…

Frailty is not just a static measure and can change overtime…our latest on dynamic frailty assessment in MM with @tanyawildes Ajay Major, MD, MBA HEI @ECRI_RESEARCH Hamilton Health Sciences nature.com/articles/s4140…

🔊OUT NOW: This all-new episode of The HemOnc Pulse features @AncaPrica and Abi Vijenthira, MD, both of Princess Margaret Cancer Centre, discussing their analysis on the cost-effectiveness of DLBCL therapies with host chadi nabhan MD, MBA, FACP. Listen: buff.ly/3BD6RaQ Society of Hematologic Oncology (SOHO)

Its official...We are CIHR funded- our phase III RCT in MM (ranked 1/66!). Years of hard work and so much gratitude to so many around me who have helped and kept my idea alive. Huge step for us in Canada with CCTG Myeloma Canada @arleighmccurdy Annette Hay

Treatment patterns and health care utilization among TCE MM patients . We follow over 16000 NDMM patients through treatment trajectory....What is our benchmark in Canada and how can we improve upon it with Alissa Visram Hsien Seow PhD @ECRI_RESEARCH McMaster Research @CADTH_ACMTS

We are hiring!! Come join our malignant hematology team or if you’re really 😎 , come join specifically our myeloma team, we are aiming to build an incredible myeloma program, interested in helping create it? With McMaster Research @ECRI_RESEARCH Anthony Rullo: chemically modulating proximity Gwynivere Davies

Happy #AdvanceCarePlan day in 🇨🇦 ! Never too early to think about what’s important to you and the future. Advance Care Planning Canada Not just in 🇨🇦, but global movement to talk ACP, including in 🇬🇧 @ACPDay2024

Last night, we honoured our 2024 Mentor of the Year, Rosalyn Juergens from the Juravinski Cancer Center! Congratulations Dr. Juergens 🎊 Caroline Chung, MD Hamilton Health Sciences #mentor #wincalinc #mentorship #leadership #radiationoncology #womenincancer #JHCC

A fantastic recognition for Dr Hira Miam who was honoured tonight with the Dr Ralph Meyer Phase III Young Investigators Award Presented to a young investigator who contributed significantly to the conduct of a Phase III trial McMaster Health Sciences Hamilton Health Sciences #CCTG2024

Finally published - doi.org/10.1002/146518… - what a journey it was. Collaboration to complete larger studies and more stringent protocols accounting for off protocol transfusions are needed if the question is ever going to be answered Joanne Britto Tyler Pitre, MD🇨🇦 Emily Sirotich, PhD

Happy to share our review out AmericanJournalofHematology with Rafael Fonseca MD 🦔🇺🇸🏜🇲🇽 Martin Kaiser with McMaster Research @ECRI_RESEARCH Hamilton Health Sciences Myeloma Canada Still high risk? A review of translocation t(14;16) in multiple myeloma pubmed.ncbi.nlm.nih.gov/38874195/

Congratulations to two of our oncology chairs, Dr. Tobias Berg and Dr. Ashirbani Saha, on their re-appointments for a second term! McMaster Health Sciences Hamilton Health Sciences #cancerresearch

Always good to see negative trials published. RGDP with ibrutinib no better (in terms of overall response) and more toxic (more bacterial & fungal infns) compared with RGDP in rr DLBCL. #lymsm onlinelibrary.wiley.com/doi/10.1111/bj…